A highly sensitive method for the detection of recombinant PERV-A/C env RNA using next generation sequencing technologies
Abstract Several xenogenic cell-based therapeutic products are currently under development around the world for the treatment of human diseases. Porcine islet cell products for treating human diabetes are a typical example. Since porcine cells possess endogenous retrovirus (PERV), which can replicat...
Guardado en:
Autores principales: | Ken Kono, Kiyoko Kataoka, Yuzhe Yuan, Keisuke Yusa, Kazuhisa Uchida, Yoji Sato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4ce8d8a941048a3b91f1d31adb3cd5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination.
por: Francesca Di Giallonardo, et al.
Publicado: (2013) -
CHARACTERIZATION OF ENTEROVIRUSES BY NEXT-GENERATION SEQUENCING
por: M. Bessaud, et al.
Publicado: (2018) -
Probing the SELEX process with next-generation sequencing.
por: Tatjana Schütze, et al.
Publicado: (2011) -
Molecular sampling at logarithmic rates for next-generation sequencing.
por: Caroline Horn, et al.
Publicado: (2019) -
Next-generation sequence analysis of cancer xenograft models.
por: Fernando J Rossello, et al.
Publicado: (2013)